Molecular characterization of chronic cutaneous wounds reveals subregion- and wound type-specific differential gene expression.

Autor: Richards SM; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Gubser Keller C; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Kreutzer R; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Department of Pathology, AnaPath Services GmbH, Liestal, Switzerland., Greiner G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Ley S; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Doelemeyer A; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Dubost V; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Flandre T; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Kirkland S; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Harvantis Pharma Consulting Ltd, London, UK., Carbone W; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Research and Development Coordinator, ELI TechGroup Corso Svizzera, Torino, Italy., Pandya R; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Knehr J; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Roma G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Discovery Data Science, GSK Vaccines, Siena, Italy., Schuierer S; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Bouchez L; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Therapeutics Department, Executive in Residence, General Inception, Basel, Switzerland., Seuwen K; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Aebi A; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Westhead D; Leeds Institute of Data Analytics, University of Leeds, Leeds, UK., Hintzen G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Translational Science, Affimed GmbH, Mannheim, Germany., Jurisic G; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Hossain I; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Neri M; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Manevski N; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; Translational PKPD and Clinical Pharmacology, Pharmaceutical Sciences, pRED, F. Hoffmann-La Roche AG, Basel, Switzerland., Balavenkatraman KK; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Moulin P; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Begrich A; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Bertschi B; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Huber R; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Bouwmeester T; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Driver VR; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.; INOVA Healthcare, Wound Healing and Hyperbaric Centers, Falls Church, Virginia, USA., von Schwabedissen M; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Schaefer D; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Wettstein B; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Wettstein R; Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Ruffner H; Novartis Biomedical Research, Novartis Pharma AG, Basel, Switzerland.

Publikováno v: International wound journal [Int Wound J] 2024 Apr; Vol. 21 (4), pp. e14447. Date of Electronic Publication: 2023 Dec 27.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

754P A phase I/IIa dose escalation study of AFM24 in patients with epidermal growth factor receptor-expressing (EGFR) solid tumors: Results from phase I

Autor: El-Khoueiry, A.B., Lopez, J.S., Saavedra, O., Awad, M., Thomas, J., Tiu, C., Garralda, E., Rehbein, B., Hintzen, G., Pietzko, K., Raab, C., Rajkovic, E., Ravenstijn, P., Rivas, D., Emig, M.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S889-S889

Analysis of CD1a-Positive Monocyte-Derived Cells in the Regional Lymph Nodes of Patients with Gallbladder Cancer.

Autor: Maeda, Sachiko^1,2 (AUTHOR) f8642@cc.saga-u.ac.jp, Kai, Keita³ (AUTHOR) kaikeit@cc.saga-u.ac.jp, Kawasaki, Kanako¹ (AUTHOR), Tanaka, Tomokazu² (AUTHOR) idetaka@cc.saga-u.ac.jp, Ide, Takao² (AUTHOR) noshiro@cc.saga-u.ac.jp, Noshiro, Hirokazu² (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12763. 13p.

Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer.

Autor: Wang, Yan¹ (AUTHOR), Chen, Yanhong¹ (AUTHOR), Ji, Ding-Kun² (AUTHOR), Huang, Yuelin¹ (AUTHOR), Huang, Weixi¹ (AUTHOR), Dong, Xue¹ (AUTHOR), Yao, Defan^1,3 (AUTHOR) yaodefan@xinhuamed.com.cn, Wang, Dengbin^1,3 (AUTHOR) wangdengbin@xinhuamed.com.cn

Publikováno v: Journal of Nanobiotechnology. 8/1/2024, Vol. 22 Issue 1, p1-20. 20p.